Skip to main content
OpenTrials
Completed

NCT Number: NCT02097212

Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea

The investigators hypothesize that there is a strong correlation between OSA and TBM/HDAC. Our hypothesis is based on the similarities in mechanism (airway collapse), symptoms (daytime and nocturnal dyspnea) predisposing conditions (obesity and neuromuscular abnormalities of the chest wall and the diaphragm), and effect of interventions (CPAP and BIPAP) in these diseases.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Tracheobronchomalacia (TBM) and HyperDynamic Airway Collapse (HDAC) are two distinct airway diseases that lead to airway collapse which can in turn lead to the symptoms of dyspnea, cough, and inability to expectorate sputum effectively. TBM entails flaccid tracheal and bronchial cartilages leading to airway collapse, emanating primarily from the anterior wall of the lumen. It is seen in conditions such as Relapsing Polychondritis and saber sheath tracheal deformity. HDAC on the other hand is the hyper-flaccidity of the membranous portion of the tracheobronchial tree leading to airway collapse. This condition is commonly seen with obesity and severe emphysema. TBM and HDAC frequently coexist.

In patients with TBM/HDAC sleep disorders are common. Patients often complain of poor quality sleep, snoring, daytime fatigue, and somnolence. These patients are often diagnosed with Obstructive Sleep Apnea (OSA) upon workup.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females and males ages 18-80 years old
  • Able and willing to provide written informed consent
  • Existing diagnosis of TBM or HDAC or both
  • No pre-existing diagnosis of OSA
  • No history of reconstructive surgery of chest wall or diaphragm

Exclusion criteria

  • Inability to provide informed consent
  • Non-English speaking
  • Poorly controlled congestive heart failure
  • Untreated Insomnia
  • Severe Coronary artery disease with active symptoms of angina
  • Patient is pregnant, or plans to become pregnant in next 3 months
  • Moderate to severe bronchiectasis
  • Severe untreated gastroesophageal disease (GERD).
  • Moderate to large hiatal hernia deemed to be atleast in part responsible for TBM/HDAC
  • Airway obstruction not caused by TBM /HDAC or secondary TBM/HDAC caused by conditions such as Chronic Obstructive Pulmonary Disease (COPD).
  • Active or recent (with in last one year) cancer or cancer therapy (chemotherapy, radiation therapy or surgery)
  • Inability to properly perform the home sleep test
  • Unreliable test data after 2 attempts
  • BMI>45

Treatment and study plan

Primary outcomes

  1. Epworth Sleepiness Scale

    Time frame: Baseline

    The Epworth Sleepiness Scale is widely used in the field of sleep medicine as a subjective measure of a patient's sleepiness. The test is a list of eight situations in which you rate your tendency to become sleepy on a scale of 0, no chance of dozing, to 3, high chance of dozing.

Sponsors and collaborators

Lead sponsor

National Jewish Health

Other

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Mar 27, 2014
Registry last updated
Mar 29, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.